TY  - GEN
AU  - Bendell,Johanna C
AU  - Joseph,Mathew
AU  - Barnes,Kirk
AU  - Mainwaring,Mark
AU  - Shipley,Dianna
AU  - Reddy,Chandra
AU  - Blakely,Laura
AU  - Blachly,Ronald
AU  - Lane,Cassie M
AU  - Earwood,Chris
AU  - Kuzur,Michel
TI  - A Phase-2 Trial of Single Agent Axitinib as Maintenance Therapy Following First-Line Treatment With Modified FOLFOX/Bevacizumab in Patients With Metastatic Colorectal Cancer
SN  - 1532-4192
PY  - 2017///0921
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - therapeutic use
KW  - Axitinib
KW  - Bevacizumab
KW  - administration & dosage
KW  - Colorectal Neoplasms
KW  - drug therapy
KW  - Disease-Free Survival
KW  - Female
KW  - Humans
KW  - Imidazoles
KW  - Indazoles
KW  - Middle Aged
KW  - Neoplasm Metastasis
KW  - Protein Kinase Inhibitors
KW  - Treatment Outcome
N1  - Publication Type: Clinical Trial, Phase II; Journal Article
UR  - https://doi.org/10.1080/07357907.2017.1310221
ER  -